Interleukin-1α release during necrotic-like cell death generates myeloid-driven immunosuppression that restricts anti-tumor immunity
Kay Hänggi(University of Zurich), Brian Ruffell(Moffitt Cancer Center)
Cited by 52
Related Papers
Dendritic Cells and Their Role in Immunotherapy
|Frontiers in Immunology|2020|481
Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression
|Nature Materials|2020|307
RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function
|Cell Death and Disease|2017|79
TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8<sup>+</sup> T cell and XCR1<sup>+</sup> dendritic cell spatial co-localization
|Journal for ImmunoTherapy of Cancer|2022|49